Navigation Links
Baxa Announces Colorado BioScience Association Sponsorship
Date:5/1/2008

ENGLEWOOD, Colo., May 1 /PRNewswire/ -- Baxa Corporation announces its 2008 sponsorship for the Colorado BioScience Association (CBSA). CBSA Board Chair Jack Wheeler (founder of MicroPhage Inc.) recognized Baxa, along with the other 2008 Association sponsors, during the CBSA Annual All-Member Meeting held April 29th at the University Club in Denver. Baxa Corporation has been a member of the CBSA since its inception. Company founder Brian Baldwin was one of the founders and the first President of its predecessor organization, the Colorado Medical Device Association.

"The Colorado BioScience Association works on behalf of our industry at both the state and national level," notes Baxa Chairman and CEO Greg Baldwin of the sponsorship. "We support them because their work to grow the industry makes Colorado, and especially the Denver metropolitan area, a better place for all bioscience and medical device companies to do business."

Through the years, Baxa has provided support for CBSA events and activities without a formal sponsorship grant. The company's investment underlines its support of CBSA initiatives for industry growth, networking and professional education, as well as for the role it has played in promoting Colorado and Denver as leaders in the technology industry. In a business competitiveness report from 2004 cited on the CBSA Web site, Colorado is ranked as the #5 state and Denver as the #5 city for economic development and commitment to technology growth (http://www.cobioscience.com/factsheet.php).

In addition to publicizing the accomplishments of state bioscience companies, the Colorado BioScience Association works to develop partnerships with Colorado's life science research institutions to increase the commercialization of Colorado-based technologies. As the industry's professional voice, CBSA fosters industry growth and investment. The organizational is also a strong force in education and development for the industry.

Baxa Corporation is a Denver-based medical device manufacturer that employs more than 400 associates worldwide. The company provides in-kind and monetary support for a variety of local, national and international organizations as part of its community stewardship and social responsibility programs.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.

About Colorado BioScience Association (CBSA)

CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. Visit http://www.cobioscience.com.

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com

http://www.cobioscience.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Anesiva Announces First Quarter 2008 Financial Results Conference Call and Webcast
3. Anesiva Announces Expansion of Zingo Agreement in Europe
4. Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results
5. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
6. BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center
7. Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands
8. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
9. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
10. BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advisory Board
11. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 23, 2017 , ... Federal funding for basic and ... enabler of life-saving medical and other vital technologies — deserves continued support, say leaders ... in the scientific community today in responding to the President’s budget request for Fiscal ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... unlimited source of human cardiovascular cells for research and the development of ... it possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to varying ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... applications, has announced a facility expansion to accommodate its rapid growth. , The ... new workspace and renovation of the existing areas. The expansion includes, a state-of-the-art ...
(Date:5/22/2017)... Boston, MA (PRWEB) , ... May 22, 2017 , ... ... evidence, has expanded to the East Coast. It has opened an office in downtown ... innovative therapies are finding it increasingly more important to generate evidence on the value ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):